Socioeconomic status influences the toll paediatric hospitalisations take on families: a qualitative study

Andrew Finkel Beck1, Lauren G Solan2, Stephanie A Brunswick3

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

BMJ Quality & Safety
|July 30, 2016
PubMed

Insights

Hospitalizations and transitions home present unique challenges for families, especially those with lower socioeconomic status (SES). Addressing these disparities in care is crucial for preventing adverse health outcomes and reducing post-discharge inequities.

Area of Science:

  • Healthcare Disparities
  • Pediatric Health Outcomes
  • Socioeconomic Factors in Health

Background:

  • Hospitalizations and transitions home can increase patient risk for adverse health outcomes.
  • Disparities in healthcare experiences may arise from differences in family resources and support systems.
  • These disparities can perpetuate inequities in post-discharge care.

Purpose of the Study:

  • To qualitatively explore how hospitalization and transition experiences differ among families with varying socioeconomic status (SES).

Main Methods:

  • Conducted focus groups and individual interviews with caregivers of recently discharged children.
  • Stratified sessions based on SES, using census tract poverty rates (<15% or ≥15%).
  • Employed an open-ended, semistructured question guide to assess family experiences.

Main Results:

  • 61 caregivers participated; 56% were from low SES backgrounds (≥15% poverty rate).
  • Identified interrelated logistical, emotional, and financial challenges.
  • Themes related to hospitalization and transition experiences were described differently across SES strata.

Conclusions:

  • Lower SES families face distinct challenges during hospitalizations and transitions.
  • Tailored care delivery models and discharge planning are needed to mitigate adverse events and reduce post-discharge disparities.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
779